Christopher A. Kroeger sold $5.4M of MapLight Therapeutics (MPLT)

Executed Jul 15, disclosed Jul 18, 2 days later.

Value, as filed

$5.4M

147,457 sh across 5 lots

Executed

Jul 15

the trade date, as filed

Disclosed

Jul 18

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Christopher A. Kroeger Chief Executive Officer profile →

Christopher A. Kroeger (Chief Executive Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in MapLight Therapeutics, Inc. (MPLT). The largest single filing was $5.4M of MPLT (147,457 sh across 5 lots, as filed), executed Jul 15.

The name

MPLT

MapLight Therapeutics, Inc. MPLT · Healthcare · 30 filings in 24 months ticker →

Healthcare · MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Christopher A. Kroeger in MPLT

MPLTSALE MapLight Therapeutics, Inc. $3.2M
118,037 sh × $27.19
Exec May 18
Filed May 18 · 5:30 PM ET MPLTSALE MapLight Therapeutics, Inc. $1.8M
62,485 sh across 5 lots
Exec May 7
Filed May 11 · 5:30 PM ET MPLTSALE MapLight Therapeutics, Inc. $1.4M
47,808 sh across 5 lots
Exec May 4
Filed May 6 · 5:30 PM ET MPLTSALE MapLight Therapeutics, Inc. $454K
16,710 sh across 2 lots
Exec Apr 15
Filed Apr 17 · 5:30 PM ET